Glomerular crescent-related biomarkers in a murine model of chronic graft versus host disease

Nephrology Dialysis Transplantation

Volumn 21, Issue 2, 2006, Pages 288-298

  Ka, Shuk Man ^a   Rifai, Abdalla ^c   Chen, Jan Hen ^a   Cheng, Chao Wen ^a   Shui, Hao Ai ^a   Lee, Herng Sheng ^a   Lin, Yuh Feng ^b   Hsu, Lai Fa ^a   Chen, Ann ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

Anxa2; Crescentic lupus nephritis; Laser microdissection; S100a6; Sparc; Tmsb10

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; COMPLEMENTARY DNA; LIPOCALIN; LIPOCORTIN 2; MOLECULAR MARKER; OSTEONECTIN; OSTEOPONTIN; PROTEIN S 100; THYMOSIN BETA10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA MICROARRAY; GENE EXPRESSION; GENETIC CODE; HYBRID; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INJECTION; LASER MICRODISSECTION; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE; MICROMORPHOLOGY; MOUSE; MOUSE STRAIN; NON INVASIVE MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN URINE LEVEL; PROTEINURIA; QUANTITATIVE ANALYSIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GRAFT VS HOST DISEASE; LUPUS NEPHRITIS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA;

EID: 31544478514     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi229     Document Type: Article

References (25)

1. Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int 2003; 63: 1164-1177
2. Alpers CE. The kidney. In: Kumar V, Abbas AK, Fausto N (eds), Robbins and Cotran Pathologic Basis of Disease, 7th edn. Elsevier Saunders, Philadelphia, PA; 2005: 976
3. Aben JA, Hoogervorst DA, Paul LC et al. Genes expressed by the kidney, but not by bone marrow-derived cells, underlie the genetic predisposition to progressive glomerulosclerosis after mesangial injury. J Am Soc Nephrol 2003; 14: 2264-2270
4. Eikmans M, Baelde HJ, Hagen EC et al. Renal mRNA levels as prognostic tools in kidney diseases. J Am Soc Nephrol 2003; 14: 899-907
5. Koop K, Eikmans M, Baelde HJ et al. Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol 2003; 14: 2063-2071
6. Bruijn JA, van Elven EH, Hogendoorn PC et al. Murine chronic graft-versus-host disease as a model for lupus nephritis. Am J Pathol 1988; 130: 639-641
7. Chen A, Sheu LF, Ho YS et al. Administration of dexamethasone induces proteinuria of glomerular origin in mice. Am J Kidney Dis 1998; 31: 443-452
8. Lan HY, Yu XQ, Yang N et al. De novo glomerular osteopontin expression in rat crescentic glomerulonephritis. Kidney Int 1998; 53: 136-145
9. Han H, Bearss DJ, Browne LW et al. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res 2002; 62: 2890-2896
10. Sasaki T, Hohenester E, Gohring W et al. Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin. EMBO J 1998; 17: 1625-1634
11. Motamed K, Sage EH. SPARC inhibits endothelial cell adhesion but not proliferation through a tyrosine phosphorylation-dependent pathway. J Cell Biochem 1998; 70: 543-552
12. Funk SE, Sage EH. Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts. J Cell Physiol 1993; 154: 53-63
13. McCreary V, Kartha S, Bell GI et al. Sequence of a human kidney cDNA clone encoding thymosin beta 10. Biochem Biophys Res Commun 1988; 152: 862-866
14. Abiko T, Sekino H. Synthesis of the nonatriacontapeptide corresponding to the entire amino acid sequence of calf thymosin beta 8 and its effect on the impaired T-cell subsets in patients with lupus nephritis. Chem Pharm Bull (Tokyo) 1983; 31: 1320-1329
15. Mishra J, Ma Q, Prada A et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003; 14: 2534-2543
16. Zhu B, Suzuki K, Goldberg HA et al. Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: Evidence of a role for an intracellular form of osteopontin. J Cell Physiol 2004; 198: 155-167
17. Hraba-Renevey S, Turler H, Kress M et al. SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism. Oncogene 1989; 4: 601-608
18. Yu XQ, Wu LL, Huang XR et al. Osteopontin expression in progressive renal injury in remnant kidney: Role of angiotensin II. Kidney Int 2000; 59: 1469-1480
19. Hudkins KL, Giachelli CM, Eitner F et al. Osteopontin expression in human crescentic glomerulonephritis. Kidney Int 2000; 57: 105-116
20. Wuthrich RP, Fan X, Ritthaler T et al. Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis. Autoimmunity 1998; 28: 139-150
21. Okada H, Moriwaki K, Konishi K et al. Tubular osteopontin expression in human glomerulonephritis and renal vasculitis. Am J Kidney Dis 2000; 36: 498-506
22. Garcia GE, Xia Y, Harrison J et al. Mononuclear cell-infiltrate inhibition by blocking macrophage-derived chemokine results in attenuation of developing crescentic glomerulonephritis. Am J Pathol 2003; 162: 1061-1073
23. Lewington AJ, Padanilam BJ, Hammerman MR. Induction of calcyclin after ischemic injury to rat kidney. Am J Physiol 1997; 273: F380-F385
24. Mizutani A, Usuda N, Tokumitsu H et al. CAP-50, a newly identified annexin, localizes in nuclei of cultured fibroblast 3Y1 cells. J Biol Chem 1992; 267: 13498-13504
25. Babiychuk EB, Palstra RJ, Schaller J et al. Annexin VI participates in the formation of a reversible, membrane-cytoskeleton complex in smooth muscle cells. J Biol Chem 1999; 274: 35191-35195